BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8743514)

  • 1. Blood pressure and risk of end-stage renal disease in a screened cohort.
    Iseki K; Ikemiya Y; Fukiyama K
    Kidney Int Suppl; 1996 Jun; 55():S69-71. PubMed ID: 8743514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
    Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
    Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
    Iseki K; Kinjo K; Iseki C; Takishita S
    Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.
    Hsu CY; McCulloch CE; Darbinian J; Go AS; Iribarren C
    Arch Intern Med; 2005 Apr; 165(8):923-8. PubMed ID: 15851645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort.
    Iseki K; Tozawa M; Ikemiya Y; Kinjo K; Iseki C; Takishita S
    Clin Exp Nephrol; 2005 Mar; 9(1):46-52. PubMed ID: 15830273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of end-stage renal disease and body mass index in a screened cohort.
    Iseki K; Ikemiya Y; Fukiyama K
    Kidney Int Suppl; 1997 Dec; 63():S169-70. PubMed ID: 9407450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.
    Munkhaugen J; Lydersen S; Widerøe TE; Hallan S
    Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure and end-stage renal disease in men.
    Klag MJ; Whelton PK; Randall BL; Neaton JD; Brancati FL; Ford CE; Shulman NB; Stamler J
    N Engl J Med; 1996 Jan; 334(1):13-8. PubMed ID: 7494564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension awareness, treatment, and control in chronic kidney disease.
    Sarafidis PA; Li S; Chen SC; Collins AJ; Brown WW; Klag MJ; Bakris GL
    Am J Med; 2008 Apr; 121(4):332-40. PubMed ID: 18374693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term renal function in primary hypertension. An epidemiological and pathophysiological study.
    Siewert-Delle A
    Scand J Urol Nephrol Suppl; 1999; 199():1-36. PubMed ID: 10349677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan.
    Iseki K; Iseki C; Ikemiya Y; Kinjo K; Takishita S
    Hypertens Res; 2007 Feb; 30(2):167-74. PubMed ID: 17460387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family history of end-stage renal disease among hemodialyzed patients in Poland.
    Gumprecht J; Zychma MJ; Moczulski DK; Gosek K; Grzeszczak W
    J Nephrol; 2003; 16(4):511-5. PubMed ID: 14696752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing gender difference in the incidence of chronic dialysis therapy in Japan.
    Iseki K; Nakai S; Shinzato T; Nagura Y; Akiba T;
    Ther Apher Dial; 2005 Oct; 9(5):407-11. PubMed ID: 16202016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in body mass index and its impact on blood pressure: a prospective population study.
    Drøyvold WB; Midthjell K; Nilsen TI; Holmen J
    Int J Obes (Lond); 2005 Jun; 29(6):650-5. PubMed ID: 15809666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four blood pressure indexes and the risk of stroke and myocardial infarction in Japanese men and women: a meta-analysis of 16 cohort studies.
    Miura K; Nakagawa H; Ohashi Y; Harada A; Taguri M; Kushiro T; Takahashi A; Nishinaga M; Soejima H; Ueshima H;
    Circulation; 2009 Apr; 119(14):1892-8. PubMed ID: 19332464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.